Get the Stockscreener App
0.4664
4.53%
-0.0168
Mdxhealth Sa stock is traded at $0.4664, with a volume of 159.63K.
It is down -4.53% in the last 24 hours and down -18.48% over the past month.
MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.
See More
Previous Close:
$0.4832
Open:
$0.4821
24h Volume:
159.63K
Relative Volume:
0.21
Market Cap:
$23.96M
Revenue:
$110.97M
Net Income/Loss:
$-33.18M
P/E Ratio:
-0.7095
EPS:
-0.6574
Net Cash Flow:
$-11.80M
1W Performance:
+12.35%
1M Performance:
-18.48%
6M Performance:
-86.19%
1Y Performance:
-78.44%
1-Day Range:
$0.45
$0.4896
1-Week Range:
$0.4139
$0.54
52-Week Range:
$0.40
$5.33
Mdxhealth Sa Stock (MDXH) Company Profile
Compare MDXH vs TMO, DHR, IDXX, NTRA, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MDXH
Mdxhealth Sa
|
0.4664 | 24.48M | 110.97M | -33.18M | -11.80M | -0.6574 |
TMO
Thermo Fisher Scientific Inc
|
517.04 | 194.52B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
193.56 | 140.09B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
565.02 | 44.00B | 4.45B | 1.10B | 1.06B | 13.59 |
NTRA
Natera Inc
|
283.60 | 40.00B | 2.50B | -226.32M | 71.51M | -1.6412 |
WAT
Waters Corp
|
377.46 | 37.24B | 3.77B | 449.25M | 240.68M | 7.8556 |
Mdxhealth Sa Stock (MDXH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-17-25 | Initiated | Craig Hallum | Buy |
| Oct-31-24 | Initiated | Lake Street | Buy |
| May-31-23 | Initiated | TD Cowen | Outperform |
| Jul-18-22 | Resumed | Oppenheimer | Outperform |
Mdxhealth Sa Stock (MDXH) Latest News
MDxHealth SA explores US growth opportunities as diagnostics demand evolves - AD HOC NEWS
Price to book forward of MDxHealth SA – NASDAQ:MDXH - TradingView
Mdxhealth receives NASDAQ non-compliance notice after $1 bid price breach - MSN
Mdxhealth Faces Nasdaq Compliance Deadline After Minimum Bid Price Breach - TipRanks
Nasdaq warns mdxhealth (NASDAQ: MDXH) on $1 bid rule, eyes reverse split - Stock Titan
Mdxhealth receives Nasdaq minimum bid price deficiency notice - Investing.com
MDxHealth Gets Nasdaq Non-Compliance Notice - marketscreener.com
Mdxhealth Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency - The Manila Times
Mdxhealth gets 180 days to fix Nasdaq bid-price issue - Stock Titan
MDxHealth Study Backs Prostate Cancer Test - Orange County Business Journal
MDxHealth SA(NasdaqCM: MDXH) added to Russell Microcap Value Benchmark Index - marketscreener.com
Mdxhealth study published in European Urology Oncology - Investing.com
Mdxhealth study published in European Urology Oncology By Investing.com - Investing.com India
Mdxhealth Announces Peer-Reviewed Publication of Oxford GPS-ProMPT Study in European Urology Oncology, Establishing Scientific Foundation for the Landmark GPS-ProtecT Randomized Controlled Trial - The Manila Times
Mdxhealth study finds 92% six-year freedom from failure - Stock Titan
MDxHealth SA(NasdaqCM: MDXH) added to Russell 3000E Value Benchmark - marketscreener.com
MDxHealth S.A. Actuals & Estimates (NASDAQ:MDXH) - TradingView
MDxHealth S.A. Actuals & Estimates (SWB:O6C1) - TradingView
MDxHealth SA (MDXH) Valuation: PE, PB & Fair Value Analysis - TradingKey
MDXH Forecast — Price Target — Prediction for 2027 - TradingView
MDxHealth SA (MDXH) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
MDXH PE Ratio & Valuation, Is MDXH Overvalued - Intellectia AI
MDxHealth SA (MDXH) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
MDxHealth StockThursday technical snapshot around key support - AD HOC NEWS
MDxHealth SA (MDXH) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
MDxHealth SA (MDXH) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
MDxHealth SA (MDXH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
MDxHealth SA (MDXH) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
MDxHealth SA (MDXH) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
MDxHealth SA (MDXH) Institutional Confidence - TradingKey
MDxHealth (MDXH) Hovers Near Key Support Level After Marginal DeclineWyckoff Upthrust - newsline.com
· Analyst Forecast - MLQ.ai
MDxHealth (MDXH) Slips 5.7% as Shares Test Key Support at $0.54Ease of Movement - newsline.com
MDxHealth (MDXH) director Michael Holder receives 10,000 share option grant - Stock Titan
MDxHealth (NASDAQ: MDXH) grants Joseph Sollee 237,100 share options - Stock Titan
Director Don M. Hardison granted 10,000 MDxHealth (MDXH) options at $0.76 - Stock Titan
MDxHealth (MDXH) awards new share options to finance VP - Stock Titan
MDxHealth (NASDAQ: MDXH) CEO granted 942,200 share options at $0.76 strike - Stock Titan
MDxHealth (MDXH) director-linked entity receives 10,000 share options at $0.76 - Stock Titan
MDxHealth (NASDAQ: MDXH) grants CCO John Bellano 333,000 share options - Stock Titan
MDxHealth (MDXH) director granted options on 10,000 shares - Stock Titan
MDxHealth (MDXH) director Koen Hoffman awarded 10,000 share options via Ahok BV - Stock Titan
MDxHealth (MDXH) Edges Higher as Stock Tests Key Resistance Near $0.80Sentiment Shift - thelegaladvocate.com
MDxHealth (MDXH) VP Brendan O’Connell files initial Form 3 ownership report - Stock Titan
MDXH - Finviz
MDxHealth (MDXH) Slides 6.25% as Cancer Diagnostics Stock Tests Key Support LevelEnding Diagonal - thelegaladvocate.com
MDxHealth to Shut Down Resolve UTI Business - Orange County Business Journal
MDXHealth Q1 2026 Earnings: EPS Miss Weighs on Shares as Company Navigates Diagnostic MarketEarnings Call Transcript - The Legal Advocate
MDxHealth SA (MDXH) Stock Analysis: -3.98% Loss — Key Levels 2026-05-21Fair Value Gap - Newser
Mdxhealth Refocuses on Prostate Franchise Amid Headwinds - The Globe and Mail
MDxHealth SA (MDXH) Stock Analysis: +4.85% Gain — What to Watch 2026-05-20Upthrust Pattern - Newser
Mdxhealth Sa Stock (MDXH) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.26%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):